InvestorsHub Logo
Followers 40
Posts 3318
Boards Moderated 0
Alias Born 08/18/2009

Re: None

Tuesday, 10/29/2019 12:56:28 PM

Tuesday, October 29, 2019 12:56:28 PM

Post# of 1140
Can anyone clarify the following statement by the CEO in the latest presentation: "we have the rights to use C1 and sub-license it exclusively until 2029 for animal and human health"? Does this imply that they lose their exclusivity on C1 uses in pharma at that time, and if so.. to whom? TIA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DYAI News